RMD
RESMED INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$229.94
−9.05%Price chart
Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30
Key dataOct 30, 2026
Open$247.42
From 52W high−16.68%
Volume3.44M
Market cap$32.34B
P/E (TTM)28.5x
P/S (TTM)5.6x
Div yield1.07%
Key dataOct 30, 2026
Open
$247.42
From 52W high
−16.68%
Volume
3.44M
Market cap
$32.34B
ValuationView details →
P/E (Fwd)
18.5x
EV/EBITDA
15.2x
P/E (TTM)
28.5x
RSI (14)
44.0
MomentumView details →
1D Return
−9.05%
YTD Return
−3.43%
SummaryUpdated Sep 1, 2026
ResMed Inc. (NYSE:RMD) is a medical device company founded in 1989 and headquartered in San Diego, California. The company went public in 1995 and has evolved from a sleep apnea device manufacturer into a comprehensive digital health platform serving patients with sleep-disordered breathing and other respiratory conditions. ResMed operates globally across approximately 140 countries, developing cloud-connected medical devices and software solutions that serve both patients in their homes and healthcare providers managing out-of-hospital care.
Similar companies
Latest newsMore news →
RESMED INC reported quarterly earnings of $2.91 per share, above the Zacks Investment Research, Inc. Consensus Estimate of $2.67 and up from $2.55 per share a year earlier.23h agoRESMED INC reported fiscal 2027 first-quarter revenue up 5.9% year over year to $1.41481 billion and operating income up 1.4% to $452.98 million, with diluted EPS of $2.92.1d agoRESMED INC increased its quarterly dividend by $0.06 to $0.66 per share.1d ago